Paradeep Parivahan to Consider Q2 Results on November 11

Paradeep Parivahan Ltd will consider its unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026 at a board meeting on 11 November 2026, with management previously guiding FY 2026-27 revenue of ₹546 crore.

When will Paradeep Parivahan consider its September 2026 results?

Paradeep Parivahan will hold a board meeting on 11 November 2026 to consider and approve unaudited financial results for the quarter and half year ended 30 September 2026. The company’s 7 November board-meeting intimation said the agenda includes both standalone and consolidated results, along with the limited review report.

The event is part of the Indian corporate results calendar for Wednesday, 11 November, which listed 141 companies. The filing does not disclose the financial figures ahead of the meeting. Revenue, profit, margins, cash flow and any management commentary for the September 2026 period will therefore become available only after the board approves the results and the company makes its formal disclosure.

The meeting covers the second quarter and first half of FY 2026-27. This makes it an important reporting point for assessing progress against the company’s stated full-year growth plans, including its expectation of a stronger second half because of seasonal trends in its operations.

What does the board-meeting filing confirm?

The filing confirms that the board will consider unaudited standalone and consolidated financial statements for the September 2026 quarter and half year. It also confirms that a limited review report will accompany the results, as required for the interim reporting process.

Paradeep Parivahan has not announced the September-quarter outcome in the information provided. As a result, it would not be appropriate to infer whether revenue, operating profit or net profit increased or declined from earlier periods. The formal results announcement will be the primary document for comparing the new period with the company’s reported financial history.

The company had earlier completed its FY 2025-26 results process. Its historical half-yearly data shows sales of ₹208 crore for the period ended March 2026, operating profit of ₹25 crore, profit before tax of ₹22 crore and net profit of ₹14 crore. These figures relate to a prior reporting period and are not an indication of the forthcoming September 2026 results.

How has Paradeep Parivahan performed in previous half years?

Paradeep Parivahan reported sales of ₹178 crore for the half year ended September 2025, compared with ₹138 crore in the corresponding September 2024 period. Operating profit rose to ₹26 crore from ₹13 crore over the same comparison, while operating profit margin improved to 15% from 9%.

For the half year ended March 2026, sales were ₹208 crore and operating profit was ₹25 crore, producing an operating profit margin of 12%. Net profit was ₹14 crore, compared with ₹16 crore for the September 2025 half year. The figures indicate that sales increased across the two reported FY 2025-26 half years, while margins and net profit varied between periods.

The company had described revenue growth of 29.4% year on year to ₹178 crore in H1 FY 2025-26. It linked its business outlook to port-sector expansion and diversification into chemical trading and civil construction.

What are Paradeep Parivahan's stated growth and margin plans?

Paradeep Parivahan has guided for revenue of ₹546 crore in FY 2026-27, after stating a FY 2025-26 top-line guidance of ₹420 crore. Management described the two-year growth trajectory as about 25% compound annual growth, while noting that the FY 2026-27 target could be revised upward if required.

The company has also said it is targeting an EBITDA margin of 16% by FY 2026-27. It reported that EBITDA margin had improved to 14.6% in a recent period, although the provided material does not identify this as the September 2026 quarter. The upcoming results will offer investors a fresh basis to track operating performance against that target.

Diversification is central to the stated plan. Paradeep Parivahan acquired a chemical business for ₹5 crore and had projected an initial revenue contribution of ₹40 crore to ₹50 crore, with a later expectation of ₹60 crore to ₹70 crore in FY 2026-27. The company has also indicated annual capital expenditure of ₹20 crore to ₹30 crore and said it had no near-term plans for equity dilution or dividend payments.

Why do the September results matter to investors?

The September results matter because they will provide the first half-year financial update against the company’s FY 2026-27 revenue guidance of ₹546 crore and its 16% EBITDA-margin target. Investors will be able to review whether logistics activity, chemical trading and other diversification efforts are contributing to revenue and profitability as management had outlined.

Port activity remains relevant to the company’s operating backdrop. Management has said cargo handling at Paradeep Port could rise from 150 million tonnes in FY 2024-25 to around 200 million tonnes in coming years, supported by new berths and expansion projects involving IOCL and JSW steel and cement. This is management’s stated industry context rather than a reported financial result for Paradeep Parivahan.

The results will also clarify the pace of expenditure and the contribution from newer businesses. Until the filing is released, there is no disclosed September 2026 revenue, profit, order update or share-price reaction attributable to the board meeting. Investors should distinguish the announced meeting date from the eventual financial outcome.

Conclusion

The 11 November board meeting is the next formal reporting event for Paradeep Parivahan, covering unaudited standalone and consolidated results for the September 2026 quarter and first half. The release will allow comparison with earlier half-year sales of ₹178 crore and ₹208 crore, as well as with the company’s operating-margin history.

The key items to watch are progress toward the ₹546 crore FY 2026-27 revenue guidance, movement toward the 16% EBITDA-margin target, and management’s update on chemical-trading revenue and capital expenditure plans. These matters are central to the company’s disclosed growth strategy and remain unresolved until the approved results are published.